Lexeo Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lexeo Therapeutics Inc
TickerLXEO
CIK #0001907108
CUSIP52886X107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address345 Park Avenue South Floor 6, New York, NY 10010
Source [EDGAR]
CIK Filing 2011 - 2026
[0001907108] 10-K
[0001907108] 10-Q
[0001907108] 3
[0001907108] 4
[0001907108] 8-K
[0001907108] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Suvretta Capital Management LLC Lexeo Therapeutics Inc [2026-04-13] 0.0
Vanguard Group Inc Lexeo Therapeutics Inc [2026-01-30] 0.0
BlackRock Inc Lexeo Therapeutics Inc [2026-01-21] 0.0
Paradigm Biocapital Advisors LP Lexeo Therapeutics Inc [2025-11-20] 0.0
RA Capital Management LP Lexeo Therapeutics Inc [2025-10-27] 0.0
Balyasny Asset Management LP Lexeo Therapeutics Inc [2025-08-14] 0.0
Vestal Point Capital LP Lexeo Therapeutics Inc [2025-08-14] 0.0
Frazier Life Sciences Public Fund LP Lexeo Therapeutics Inc [2025-06-04] 0.0
Affinity Asset Advisors LLC Lexeo Therapeutics Inc [2025-06-04] 0.0
Integrated Core Strategies US LLC Lexeo Therapeutics Inc [2025-04-28] 0.0
Mizuho Financial Group Inc Lexeo Therapeutics Inc [2025-02-13] 0.0
BlackRock Inc Lexeo Therapeutics Inc [2025-02-04] 0.0
Adage Capital Management LP Lexeo Therapeutics Inc [2024-11-12] 7.86
Janus Henderson Group PLC Lexeo Therapeutics Inc [2024-02-14] 8.7
D1 Capital Partners LP Lexeo Therapeutics Inc [2024-02-14] 0.4
Lundbeckfond Invest A/S Lexeo Therapeutics Inc [2024-02-14] 6.9
Omega Fund VI LP Lexeo Therapeutics Inc [2024-02-14] 81948.1
Longitude Capital Partners IV LLC Lexeo Therapeutics Inc [2024-02-13] 81949.6
Eventide Asset Management LLC Lexeo Therapeutics Inc [2023-12-11] 11.93
Novo Holdings A/S Lexeo Therapeutics Inc [2023-11-24] 5.1
Citadel Advisors LLC Lexeo Therapeutics Inc [2023-11-17] 8.3
Form 3/4/5 Filer 2011 - 2026
Tamayo Louis Edward
Lexeo Therapeutics Inc
Bhalla Narinder Pal
Otero Jose Manuel
Townsend Richard Nolan
Cooperstone Brenda
Altschuler Steven
Cholmondeley Paula H
Agger Mette Kirstine
van Hauwermeiren Timothy
Tanguler Tolga
Diaz Reinaldo M
Sepp-Lorenzino Laura
Adler Eric
Robertson Jenny
See Tai Sandi
Rasbach Kyle
Lundbeckfond Invest A/S
Longitude Venture Partners IV LP
Enright Patrick G
Tammenoms Bakker Juliet
Longitude Capital Partners IV LLC
McCormac Paul
Nessi Claudio
Paster Anne-Mari
Omega Fund VI GP Manager Ltd
Stampacchia Otello
Omega Fund VI LP
Omega Fund VI GP LP
Davitian Bernard
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Otero Jose Manuel
Common Stock
2026-03-13 Grant 5,930 $2.64 15,655
Townsend Richard Nolan
Common Stock
2026-03-13 Grant 2,623 $2.64 6,925
Townsend Richard Nolan
Common Stock
2026-02-18 Sell 10,173 $6.38 64,904
Otero Jose Manuel
Common Stock
2026-02-18 Sell 3,016 $6.40 19,302
Bhalla Narinder Pal
Stock Option (right to buy) · derivative
2026-02-13 Grant 297,000 $0.00
Bhalla Narinder Pal
Common Stock
2026-02-13 Grant 49,500 $0.00
Tamayo Louis Edward
Common Stock
2026-02-04 Grant 44,665 $0.00
Townsend Richard Nolan
Common Stock
2026-02-04 Grant 161,665 $0.00
Otero Jose Manuel
Common Stock
2026-02-04 Grant 65,000 $0.00
Townsend Richard Nolan
Stock Option (right to buy) · derivative
2026-02-04 Grant 646,665 $0.00
Otero Jose Manuel
Stock Option (right to buy) · derivative
2026-02-04 Grant 260,000 $0.00
Tamayo Louis Edward
Stock Option (right to buy) · derivative
2026-02-04 Grant 226,665 $0.00
Robertson Jenny
Common Stock
2025-11-18 Sell 549 $9.27 5,089
Townsend Richard Nolan
Common Stock
2025-11-18 Sell 1,127 $9.27 10,447
Common Stock
2025-11-18 Sell 721 $9.27 6,684
Adler Eric
Common Stock
2025-11-18 Sell 615 $9.27 5,701
See Tai Sandi
Common Stock
2025-11-18 Sell 386 $9.27 3,578
Otero Jose Manuel
Common Stock
2025-10-17 Sell 2,091 $8.94 18,694
See Tai Sandi
Common Stock
2025-10-17 Sell 44 $9.56 421
See Tai Sandi
Common Stock
2025-10-17 Sell 3,844 $8.94 34,365
showing 20 of 136 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 140 79,966,118
2025-12-31 146 76,466,587
2025-09-30 109 49,331,663
2025-06-30 90 42,224,484
2025-03-31 89 28,028,183
2024-12-31 91 29,519,192
2024-09-30 70 29,833,583
2024-06-30 60 26,571,038
2024-03-31 55 23,153,734
2023-12-31 32 16,184,080
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 265,697 265,697
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 159 12,745
Gamma Investing LLC [2026-06-30] DFND 247 247
Fortitude Family Office LLC [2026-06-30] SOLE 228 228
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 203
True Wealth Design LLC [2026-06-30] SOLE 0 197
Torren Management LLC [2026-06-30] SOLE 0 178
IFP Advisors LLC [2026-06-30] SOLE 172 172
Farther Finance Advisors LLC [2026-06-30] SOLE 0 159
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com